Clinical Trial

Telitacicept for the Treatment of Refractory RA

Name: Telitacicept for the Treatment of Refractory RA — clinical trial record (NCT07008196)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Record status

This record was last updated June 6, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Summary

This is a single-center, single-arm, open-label, prospective study on the efficacy and safety of Telitacicept in patients with refractory rheumatoid arthritis.

Trial Details

NCT Number	NCT07008196
Lead Sponsor	Chinese SLE Treatment And Research Group
Conditions	Rheumatoid Arthritis (RA)
Enrollment	30 participants
Start Date	2025-06-10
Primary Completion	2025-12 (estimated)
Study Completion	2026-01 (estimated)
Updated on ClinicalTrials.gov	2025-06-06